Plain-English translation of NCT06723743 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot study is testing transcutaneous auricular vagus nerve stimulation (taVNS)—a gentle, non-invasive treatment that uses tiny electrical impulses on the ear to stimulate a major nerve in your body. Researchers believe this treatment may help improve attention and memory problems that often follow traumatic brain injury, especially in veterans who also experience depression or PTSD. The goal is to see whether this medication works better than a placebo.
Many veterans with traumatic brain injury struggle with attention and memory problems, and current treatments often have limited effectiveness or cause unwanted side effects. This treatment offers a new, non-invasive option that researchers hope could provide relief without the complications of traditional approaches.
You likely qualify if…
You likely don't qualify if…
You will attend a single study visit lasting 2.5 to 3 hours at Baylor College of Medicine. During this visit, you'll complete a short questionnaire and health screening, then do two sessions of attention testing on a computer. Between each attention test, you'll receive 20 minutes of ear stimulation—one session will be active treatment and one will be a placebo (sham) session, randomly assigned. This design helps researchers compare the real treatment against placebo to see what actually works.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States